Inaugural AstraZeneca Think Tank Debate

Summary

On Thursday 1 July, the UCL Centre for Ethics & Law held its inaugural Think Tank debate in conjunction with AstraZeneca. The Think Tank series involves a selection of real-life case studies on dilemnas currently facing companies, which lie at the interface between ethics and regulatory compliance. The debates provide a forum whereby industry and academic thought leaders, along with current UCL students, can engage in a challenging exchange of ideas.

The topic of the first debate, which was led by AstraZeneca’s Global Compliance Policy Director Paul Woods, was Health Literacy and Provision of Information by Pharmaceutical Companies on Prescription Medicines. This case study formed the basis of a stimulating evening's discussion involving participants from a wide range of backgrounds and perspectives. The participants in the debate were:

• Paul Anderson, Legal Department, Nestlé UK
• Carrie Bradshaw, PhD student in environmental law, UCL
• Dr Iris Chiu, Senior Lecturer in Laws, UCL
• Dr Jillian Craigie, Research Fellow in Psychiatry and Philosophy, Centre of Medical Ethics, King’s College London
• Sam Eastwood, Partner & Head of Business Ethics and Anti-Corruption, Norton Rose LLP
• Dr Sarah Edwards, Senior Lecturer in Research Ethics and Governance, UCL
• Alex Gough, recent LLB graduate & Centre research assistant, UCL
• Stan Kirby, VP Finance Regulatory Compliance, Shell International Trading
• Dr Marc Moore, Director, UCL Centre for Ethics & Law (debate chair)
• Matthew Nicholson, PhD student in international law, UCL
• Lisa Quelch, recent LLB graduate & Senior Moots Officer, UCL Law Society
• Dr Prince Saprai, Lecturer in Laws, UCL
• Dr Nina Seppala, Lecturer in Mangement Science and Innovation, UCL
• John Smart, Head of Fraud and Investigations, Ernst & Young
• Dr Neema Sofaer, Wellcome Trust Research Fellow, Centre of Medical Ethics, King’s College London
• Simon Webley, Research Director, Institute of Business Ethics
• Richard Wiseman, Chief Ethics & Compliance Officer, Royal Dutch Shell plc
• Professor Jonathan Wolff, Professor of Philosophy, UCL
• Paul Woods, Global Compliance Policy Director, AstraZeneca (debate leader)